(Q38286460)

1 September 2017

1 reference

title

Alzheimer's disease and other dementias: advances in 2014. (English)

1 reference

1 September 2017

0 references

Randall Bateman

1

0 references

publication date

1 January 2015

1 reference

1 September 2017

1 reference

1 September 2017

volume

14

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

4-6

1 reference

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

The novel BACE inhibitor MK-8931 dramatically lowers CSF beta-amyloid in patients with mild-to-moderate Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

The A4 study: stopping AD before symptoms begin?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Molecular Imaging Insights into Neurodegeneration: Focus on Tau PET Radiotracers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Proteopathic tau seeding predicts tauopathy in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

A three-dimensional human neural cell culture model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2814%2970301-1

7 January 2021

10.1016/S1474-4422(14)70301-1

Identifiers

DOI

1 reference

1 September 2017

1 reference